Cell-free mitochondrial DNA increases in maternal circulation during healthy pregnancy: A prospective, longitudinal study

Spencer C. Cushen, Marc L. Sprouse, Alexandra Blessing, Jie Sun, Sara S. Jarvis, Yoshiyuki Okada, Qi Fu, Steven A. Romero, Nicole R. Phillips, Styliani Goulopoulou

Research output: Contribution to journalArticle

Abstract

Mitochondrial DNA (mtDNA) exposed to the extracellular space due to cell death has immunostimulatory properties. Case-control studies reported a positive association between odds of developing preeclampsia and circulating mtDNA. These findings are based on relative quantification protocols that do not allow determination of absolute concentrations of mtDNA and are highly sensitive to nuclear DNA contamination. Furthermore, circulating mtDNA concentrations in response to normal pregnancy, which is an inflammatory state characterized by continuous placental cell apoptosis, have not been established. The main objective of this study was to determine longitudinal changes in circulating mtDNA from preconception to first trimester, third trimester, and postpartum in healthy pregnant women. Absolute real-time PCR quantification of mtDNA and nuclear DNA (nDNA) was performed on whole genomic extracts from serum using TaqMan probes and chemistry. Serum cell-free mtDNA and nDNA concentrations were greater in late pregnancy as compared with early pregnancy and postpartum. Pregnant women carrying neonates at the upper quartile of birth length distribution had higher concentrations of mtDNA in late pregnancy compared with pregnancies carrying neonates at the lower quartile. The correlation between circulating mtDNA and nDNA concentrations varied by sex (i.e., pregnancies carrying female vs. male fetuses). This study is the first to establish temporal patterns of circulating cell-free mtDNA concentrations in normal human pregnancy using absolute DNA quantification techniques. Concentrations of circulating mtDNA in normal pregnancy may be used as reference values for the development of clinical prognostic or diagnostic tests in pregnant women with, or at risk of developing, gestational complications.

Original languageEnglish (US)
Pages (from-to)R445-R452
JournalAmerican Journal of Physiology - Regulatory Integrative and Comparative Physiology
Volume318
Issue number2
DOIs
StatePublished - Feb 2020

    Fingerprint

Keywords

  • Cell-free DNA
  • DNA quantification
  • Gestational age
  • Mitochondria

ASJC Scopus subject areas

  • Physiology
  • Physiology (medical)

Cite this